Ames National Corp’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$364K Sell
15,027
-915
-6% -$23.9K 0.2% 54
2026
Q1
$447K Buy
15,942
+709
+5% +$18.9K 0.27% 43
2025
Q4
$379K Sell
15,233
-939
-6% -$23.7K 0.22% 53
2025
Q3
$412K Buy
16,172
+10
+0.1% +$247 0.24% 52
2025
Q2
$392K Hold
16,162
0.25% 52
2025
Q1
$410K Hold
16,162
0.27% 51
2024
Q4
$429K Buy
+16,162
New +$438K 0.29% 50

Other funds holding PFE

Ames National Corp's PFE Position: Q2 2026 in Review

Ames National Corp reduced its Pfizer (PFE) stake by 5.7% in Q2 2026, selling an estimated $23.9K and leaving 15,027 shares worth $364K. The position accounts for 0.2% of the portfolio, ranked #54.

Ames National Corp first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $447K in Q1 2026. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ames National Corp held 15,027 shares of Pfizer worth $364K as of Q2 2026.
  • Ames National Corp sold 915 Pfizer shares in Q2 2026, an estimated $23.9K.
  • Pfizer made up 0.2% of Ames National Corp's portfolio in Q2 2026, its #54 holding.
  • Ames National Corp first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Ames National Corp's Pfizer position peaked at $447K in Q1 2026.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ames National Corp's 13F filing for Q2 2026, filed 13 Aug 2026.